Akila Bersali

Akila Bersali

Auto-generated profile, based on publicly available information

Akila Bersali

Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, TX (A.D., T.S., M.S., A.B., F.Q., M.P., F.D., K.C.E.-T., G.L., M.V., E.A.G., D.J.S.).

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2024 in Current Cardiology Reports
Verified
Journal Article
Closed access
PDF file
MSMujtaba Saeed
Mujtaba Saeed
ABAkila Bersali
Akila Bersali
ADAmr Darwish
Amr Darwish
FQFatima Qamar
Fatima Qamar
DMDimitrios Maragiannis
Dimitrios Maragiannis
DSDipan J. Shah
Dipan J. Shah

16 May 2023 in Methodist DeBakey Cardiovascular Journal
Verified
Journal Article
Open access
PDF file
ABAkila Bersali
Akila Bersali
FNFaisal Nabi
Faisal Nabi
Congenital absence of the pericardium is a rare anomaly, affecting the left pericardium (86%) more than the right, with male predilection distribution (3:1). In the majority of cases, the condition is asymptomatic. We describe a case of a 55-year-old female with a history of chronic hypercapnic respiratory failure secondary to restrictive lung disease who was referred to cardiovascular magnetic resonance (CMR) lab for shunt evaluation based on right ventricular pressure overload and paradoxical septal motion.

1 September 2026 in Circulation: Cardiovascular Imaging
Verified
Journal Article
Open access
ADAmr Darwish
Amr Darwish
DNDuc Nguyen
Duc Nguyen
TSThammarak Songsangjinda
Thammarak Songsangjinda
DKDanai Kitkungvan
Danai Kitkungvan
MSMujtaba Saeed
Mujtaba Saeed
DSDipan J. Shah
Dipan J. Shah
BACKGROUND: Mitral valve prolapse (MVP) is a common cardiac condition that is generally benign, yet a subset of affected patients develop malignant ventricular arrhythmias and sudden cardiac death. Female sex and myocardial fibrosis detected by late gadolinium enhancement on cardiovascular magnetic resonance imaging have been proposed as risk factors though their independent contributions to arrhythmic risk remain uncertain. METHODS: We conducted a prospective cohort study of 550 consecutive patients with MVP referred for cardiovascular magnetic resonance at a tertiary academic center between May 2008 and December 2021. Patients with potential confounders, including coronary artery disease, cardiomyopathy, infiltrative disease, or prior cardiac surgery, were excluded. The primary end point was a composite arrhythmic outcome comprising sudden cardiac death, aborted sudden cardiac arrest, and symptomatic sustained or inducible ventricular tachycardia or ventricular fibrillation leading to implantable cardioverter defibrillator placement or ventricular ablation at an MVP-related scar site. RESULTS: Among the 550 patients (median age, 62 [interquartile range, 52–71] years; 50% women), late gadolinium enhancement (LGE) was present in 210 (38%). Over a median follow-up of 4.4 years (interquartile range, 2.8–7.1; 2700 patient-years), 48 patients (8.7%) reached the primary end point. On univariable analysis, both female sex (hazard ratio, 3.33 [95% CI, 1.72–6.44]; P <0.001) and LGE presence (hazard ratio, 3.17 [95% CI, 1.74–5.77]; P <0.001) were significantly associated with arrhythmic events, and both remained independently associated on multivariable analysis. Women with LGE represented the highest-risk subgroup, with a 5-year event-free survival of 76.5%, compared with 98.5% in men without LGE ( P <0.001). CONCLUSIONS: In a large prospective cardiovascular magnetic resonance cohort of patients with MVP, female sex and myocardial fibrosis were each independently associated with life-threatening arrhythmic events. Their combination identified a subgroup at particularly elevated risk, highlighting the importance of integrating sex-specific factors and myocardial tissue characterization into MVP risk stratification strategies.

11 June 2026 in JACC: Cardiovascular Imaging
Verified
Journal Article
Open access
EGEl-Moatasem Gabr
El-Moatasem Gabr
MXMianli Xiao
Mianli Xiao
MSMujtaba Saeed
Mujtaba Saeed
ADAmr Darwish
Amr Darwish
ABAkila Bersali
Akila Bersali
DSDipan J. Shah
Dipan J. Shah
Patients with moderate aortic stenosis (AS) and concomitant mitral regurgitation (MR) often present with symptoms despite neither lesion individually reaching intervention thresholds. The clinical impact of this dual-valvular disease remains a knowledge gap. To evaluate the effect of concomitant MR on cardiac remodeling and clinical outcomes in patients with moderate AS using cardiac magnetic resonance (CMR) and to compare with isolated moderate and severe AS. We studied 742 patients with at least moderate AS on CMR (422 moderate AS, 320 severe AS). Patients were stratified by AS severity and MR burden. Remodeling parameters, symptoms, and outcomes—including cardiovascular (CV) death and heart failure (HF) hospitalization—were analyzed. Multivariable Cox models identified covariates associated with outcomes. Among 422 patients with moderate AS, 76 had ≥moderate MR. Compared with isolated moderate AS, combined AS+MR was associated with higher symptom burden (80.3% NYHA II-IV), more pronounced remodeling (larger indexed LV volumes, lower LVEF), and reduced aortic forward flow. Over a median 1.8 years, coexisting ≥moderate MR was independently associated with CV-death or HF-hospitalization (adjusted HR 1.86, 95% CI 1.31–2.65, p<0.001). This risk was more apparent in the low-flow subgroup (SVi ≤35 mL/m2), whereas in normal-flow patients there was a trend to increased risk that did not reach statistical significance. Outcomes in moderate AS with ≥moderate MR were worse than in isolated severe AS and comparable to severe AS populations meeting criteria for intervention. Patients with moderate AS+MR are a high-risk subgroup with high symptom burden, adverse cardiac remodeling, and poor clinical outcomes. Risk appears more pronounced in the setting of reduced forward flow (SVi ≤35 mL/m2). CMR enables quantitative assessment of dual-valvular burden and may improve risk stratification. These findings highlight a therapeutic gap and support studies of earlier intervention in this high-risk subgroup.

19 August 2026 in JACC: Cardiovascular Imaging
Verified
Journal Article
Closed access
BBBenedikt Bernhard
Benedikt Bernhard
MDMarianna Daibes
Marianna Daibes
IMIsabela Reis Marques
Isabela Reis Marques
NSNatalia Sanchez Santiuste
Natalia Sanchez Santiuste
YGYin Ge
Yin Ge
RKRaymond Y. Kwong
Raymond Y. Kwong

1 September 2016 in Journal Of Hypertension
Verified
Journal Article
Closed access
EBE. Berra
E. Berra
MGM. Gonzales
M. Gonzales
ABA. Bersali
A. Bersali
APAlexandre Persu
Alexandre Persu
Pheochromocytomas and paragangliomas (PPGLs) are catecholamine-producing tumours of chromaffin cells of the adrenal medulla and extra-adrenal paraganglia. Besides hypertension, they can be at the origin of a wide range of cardiovascular manifestations, including cardiac electric abnormalities such as long QT interval, ventricular tachycardia and torsades de pointe. However, knowledge about PPGL-related arrhythmias is scarce and mostly derived from case reports. The aim of our study was to evaluate the prevalence, nature and reversibility of cardiac electric changes and arrhythmias in patients with PPGLs. We retrospectively reviewed the medical records of patients diagnosed with PPGLs at the Cliniques Universitaires Saint-Luc (Brussels) from 1995 to 2015. All patients with secreting PPGLs in whom an electrocardiogram (ECG) was available at the time of diagnosis were eligible. Forty-five patients with secreting PPGLs were identified. The mean age at diagnosis was 48 years (12-72), 40% of patients (n = 18) were males and location of the tumour was adrenal in 87% of cases (n = 39). An ECG was available in 31 patients at the time of diagnosis. Of these, 77% (n = 24) presented at least one electric abnormality. While a positive Sokolow index was found in only 3 patients, non-specific ST-abnormalities were documented in 14 patients (45%), a T-wave inversion in at least two precordial leads in 9 (29%) and a predominant U- wave in 7 patients (23%). Finally, two patients had severe bradycardia (600 ms), two patients presented with polymorphic ventricular tachycardia related to a long QT interval at diagnosis that never recurred after surgery, and one patient was diagnosed with paroxystic atrial fibrillation, which resolved after tumour removal. We report a high prevalence (77%) of cardiac electric abnormalities in a retrospective monocentric series of PPGLs. While our findings need confirmation in larger, prospective cohorts, they strongly suggest that cardiac electric abnormalities are an underrecognized, frequent complication of catecholamine excess in patients with PPGLs, and should be an integral part of the work-up and management of these patients.